PharmaEngine announces the board resolutions on approving the Second Quarter of 2022 consolidated financial report
· Issued by PharmaEngine, Inc.
Close
Today's Information
Provided by: PharmaEngine, Inc.
SEQ_NO
1
Date of announcement
2022/07/26
Time of announcement
17:05:26
Subject
PharmaEngine Inc. announces the board resolutions
on approving the Second Quarter of 2022 consolidated
financial report
Date of events
2022/07/26
To which item it meets
paragraph 31
Statement
1.Date of the board of directors submitted or approved:2022/07/26
2.Date of the audit committee approved:2022/07/26
3.Start and end dates of financial reports or unaudited financial
information of the reporting period(XXXX/XX/XX~XXXX/XX/XX):
2022/01/01~2022/06/30
4.Operating revenue accumulated from 1/1 to end of the period
(thousand NTD):341028
5.Gross profit (loss) from operations accumulated from 1/1 to end of
the period (thousand NTD):317080
6.Net operating income (loss) accumulated from 1/1 to end of the period
(thousand NTD):213844
7.Profit (loss) before tax accumulated from 1/1 to end of the period
(thousand NTD):226401
8.Profit (loss) accumulated from 1/1 to end of the period
(thousand NTD):177704
9.Profit (loss) during the period attributable to owners of parent
accumulated from 1/1 to end of the period (thousand NTD):177704
10.Basic earnings (loss) per share accumulated from 1/1 to end of
the period (NTD):1.24
11.Total assets end of the period (thousand NTD):4206986
12.Total liabilities end of the period
(thousand NTD):478355
13.Equity attributable to owners of parent end of the
period (thousand NTD):3728631
14.Any other matters that need to be specified:Not Applicable
